Basit öğe kaydını göster

dc.contributor.authorWallach, A. I.
dc.contributor.authorJarius, S.
dc.contributor.authorKleiter, I.
dc.contributor.authorRostasy, K.
dc.contributor.authorHuppke, P.
dc.contributor.authorHemmer, B.
dc.contributor.authorPaul, F.
dc.contributor.authorProbstel, A. K.
dc.contributor.authorTintore, M.
dc.contributor.authorAmato, M. P.
dc.contributor.authorNosadini, M.
dc.contributor.authorMancardi, M. M.
dc.contributor.authorCapobianco, M.
dc.contributor.authorIlles, Z.
dc.contributor.authorAltintas, A.
dc.contributor.authorAkman-Demir, G.
dc.contributor.authorPandit, L.
dc.contributor.authorApiwattankul, M.
dc.contributor.authorHor, J. Y.
dc.contributor.authorViswanathan, S.
dc.contributor.authorQiu, W.
dc.contributor.authorFujihara, K.
dc.contributor.authorRamanathan, S.
dc.contributor.authorDale, R. C.
dc.contributor.authorBoggild, M.
dc.contributor.authorBroadley, S.
dc.contributor.authorLana-Peixoto, M. A.
dc.contributor.authorWhittam, D. H.
dc.contributor.authorChandratre, S.
dc.contributor.authorCiccarelli, O.
dc.contributor.authorde Seze, J.
dc.contributor.authorDeiva, K.
dc.contributor.authorHintzen, R. Q.
dc.contributor.authorTenembaum, S.
dc.contributor.authorCabre, P.
dc.contributor.authorWingerchuk, D. M.
dc.contributor.authorGreenberg, B.
dc.contributor.authorWeinshenker, B. G.
dc.contributor.authorKlawiter, E. C.
dc.contributor.authorBennett, J. L.
dc.contributor.authorKister, I.
dc.contributor.authorBanwell, B. L.
dc.contributor.authorTraboulsee, A.
dc.contributor.authorPohl, D.
dc.contributor.authorPalace, J.
dc.contributor.authorLeite, M. I.
dc.contributor.authorMarignier, R.
dc.contributor.authorJacob, A.
dc.contributor.authorSiva, A.
dc.contributor.authorWildemann, B.
dc.date.accessioned2021-03-06T07:59:07Z
dc.date.available2021-03-06T07:59:07Z
dc.identifier.citationWhittam D. H. , Chandratre S., Ciccarelli O., de Seze J., Deiva K., Hintzen R. Q. , Wildemann B., Jarius S., Kleiter I., Rostasy K., et al., "Treatment of MOG antibody associated disorders: results of an international survey", 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.369-371
dc.identifier.otherav_ded592c1-70f0-4ed5-9bb6-c398f4bfc12f
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/146789
dc.language.isoeng
dc.subjectSinirbilim ve Davranış
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectNöroloji
dc.subjectYaşam Bilimleri
dc.subjectKlinik Tıp
dc.subjectTemel Bilimler
dc.subjectKlinik Tıp (MED)
dc.subjectNEUROSCIENCES
dc.subjectKLİNİK NEUROLOJİ
dc.titleTreatment of MOG antibody associated disorders: results of an international survey
dc.typeBildiri
dc.contributor.departmentWalton Centre , ,
dc.identifier.volume25
dc.contributor.firstauthorID157213


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster